None listed
Conditions
Brief summary
Clinical observations suggest that the endoscopic grade of reflux oesophagitis varies significantly in patients presenting in two different hospitals A and B. These Hospitals are located in socioeconomic diverse areas, which has a big impact in health care utilization and patient’s follow-up. But this difference and a reason have not been studied prospectively so far. This is an epidemiological study using questionnaires for patients with symptoms Gastro-oesophageal Reflux Disease such as heartburn and regurgitation. Symptomatic patients referred for endoscopy will be asked complete the surveys providing information of their gastointestinal symptoms, psychological and emotional status, lifestyle and sociodemographics. Surveys are mailed in the post at time points zero, 2 months and 6 months. The aim is to assess patient’s outcome in a routine clinical care setting in a follow-up over 6 months. We like to determine possible predictors of response/non-response, symptom improvement and efficacy of the common treatment with proton pump inhibitors.
Interventions
Epidemiological study using the Bowel Disease Questionnaire, the Nepean Dyspepsia Index, the Hospital Anxiety and Depression Score, the Patient Assessment of Upper Gastrointestinal Symptom Severity Index, and the ReQuest Patient Diary. The Patient will complete the surveys providing information of their gastointestinal symptoms, psychological and emotional status, lifestyle and sociodemographics. Surveys are mailed in the post at time points zero, 2 months and 6 months.
Sponsors
Nycomed GmbH (prior Altana Pharma)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
primary complaints are reflux symptoms (heartburn, regurgitation)
Exclusion criteria
patients with significant co-morbidities, poor surgical candidate, unstable psychiatric disorder, unable to sign consent and complete questionnaires.
Outcome results
None listed